InfuSystem Holdings, Inc (INFU) stock
INFUNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 13/302% above fair value
$14.79+0.00 (0.00%)
Close on Nov 17, 2026Market cap $294.58MP/E 36.1Yield –
InfuSystem r&d expenses
Research and development expenses are spending on new products and technology.
No r&d expenses figures for InfuSystem
InfuSystem has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?